Condition
Regurgitation, Gastric
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05363553Not ApplicableCompleted
Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study
NCT04042454Not ApplicableCompletedPrimary
To Assess the Safety and Tolerance of Infant Formula With Locust Bean Gum in Infants With Regurgitation
NCT03371615Not ApplicableCompletedPrimary
Evaluation of the Tolerance and Safety of a New Partly Fermented Anti-regurgitation Infant Formula
NCT01956682Phase 4CompletedPrimary
Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying
Showing all 4 trials